Spero Therapeutics Inc (SPRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SPRO | AZN | AMGN | GILD | VRTX |
| Company | Spero Therapeutics Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 2.78 | 204.20 | 351.70 | 140.96 | 444.15 |
| High | 2.80 | 204.39 | 352.60 | 140.96 | 447.82 |
| Low | 2.64 | 199.50 | 344.21 | 138.06 | 437.19 |
| Latest | 2.65 | 201.35 | 348.05 | 139.74 | 441.68 |
| Change | -0.13 | -3.03 | -2.90 | -0.71 | -2.60 |
| % Change | -4.68% | -1.48% | -0.83% | -0.51% | -0.59% |
| Volume | 583,784 | 1,250,383 | 1,054,033 | 2,117,189 | 876,694 |
| 20-Day Average Volume | 427,761 | 1,888,831 | 2,726,896 | 5,983,646 | 1,306,542 |
| Previous Close | 2.78 | 204.38 | 350.95 | 140.45 | 444.28 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 2.51 | 195.49 | 349.65 | 139.06 | 445.16 |
| 20-Day Raw Stochastic | 67.91% | 75.21% | 50.38% | 61.48% | 50.62% |
| 20-Day Relative Strength | 57.51 | 54.93 | 45.36 | 48.64 | 46.58 |
| Weighted Alpha | +23.92 | +47.31 | +24.25 | +33.22 | -4.81 |
| Today's Opinion | 100% Buy | 88% Buy | 24% Buy | 56% Buy | 8% Buy |
| Previous Opinion | 100% Buy | 88% Buy | 56% Buy | 56% Buy | 8% Buy |
| Last Month's Opinion | 64% Buy | 56% Buy | 88% Buy | 88% Buy | 72% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.02% since 04/08/26 | -1.54% since 04/08/26 | -0.53% since 04/08/26 | -1.10% since 04/08/26 | +0.21% since 04/08/26 |
| Low | 2.63 on 04/10/26 | 199.49 on 04/15/26 | 344.21 on 04/15/26 | 137.02 on 04/13/26 | 433.68 on 04/13/26 |
| High | 2.88 on 04/14/26 | 207.30 on 04/10/26 | 359.45 on 04/09/26 | 142.97 on 04/09/26 | 447.82 on 04/15/26 |
| 1-Month | |||||
| %Chg | +3.29% since 03/13/26 | +5.91% since 03/13/26 | -4.98% since 03/13/26 | -3.46% since 03/13/26 | -5.22% since 03/13/26 |
| Low | 2.21 on 03/31/26 | 182.39 on 03/24/26 | 335.06 on 04/07/26 | 133.89 on 03/30/26 | 425.26 on 04/07/26 |
| High | 2.88 on 04/14/26 | 207.30 on 04/10/26 | 370.89 on 03/16/26 | 146.71 on 03/17/26 | 476.17 on 03/16/26 |
| 3-Month | |||||
| %Chg | +11.04% since 01/15/26 | +6.99% since 01/15/26 | +5.44% since 01/15/26 | +15.44% since 01/15/26 | +1.35% since 01/15/26 |
| Low | 2.10 on 02/03/26 | 178.08 on 01/21/26 | 321.71 on 01/20/26 | 122.10 on 01/16/26 | 425.26 on 04/07/26 |
| High | 2.88 on 04/14/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 507.92 on 03/10/26 |
| 6-Month | |||||
| %Chg | +7.03% since 10/15/25 | +18.55% since 10/15/25 | +17.04% since 10/15/25 | +18.33% since 10/15/25 | +9.06% since 10/15/25 |
| Low | 2.10 on 02/03/26 | 160.96 on 11/04/25 | 288.00 on 10/31/25 | 114.02 on 10/31/25 | 403.16 on 11/04/25 |
| High | 2.88 on 04/14/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 507.92 on 03/10/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 160,937 | 316,974,592 | 189,402,464 | 174,329,632 | 113,007,056 |
| Shares Outstanding, K | 57,891 | 1,550,908 | 539,685 | 1,241,222 | 254,360 |
| Annual Sales | 66,800,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 12,001,300,000 |
| Annual Net Income | 8,570,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 3,953,200,000 |
| Last Quarter Sales | 41,300,000 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 3,190,000,000 |
| Last Quarter Net Income | 31,520,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,191,100,000 |
| 60-Month Beta | 1.45 | 0.35 | 0.47 | 0.39 | 0.36 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.53 on 03/26/26 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 5.03 on 02/12/26 |
| Latest Earnings Date | 05/12/26 | 04/29/26 | 04/30/26 | 05/07/26 | 05/04/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | N/A |
| Next Ex-Dividends Date | 09/16/15 | 02/20/26 | 05/15/26 | 03/13/26 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 23.17 | 22.08 | 16.01 | 17.06 | 26.80 |